
Telicoplanin CAS NO.:61036-62-2
We are a manufacturer based in China. We specialize in providing high-quality Telicoplanin CAS NO.:61036-62-2 for industrial clients across various sectors. Whether you need chemicals consultation or technical support, our team is here to help.
Category:Active Pharmaceutical Ingredients Own Brand:MT /MOQ:100KG /From China/ B2B only.
Introduction
CAS NO.:61036-62-2
Molecular formula:C77H77N9O31Cl2.R
Molecular weight:
Standard:JP/ EP
Content:≥900ug/mg
Packaging:1KG/Tin
Use to:Glycopeptides
Telicoplanin: An Effective Antibacterial Agent
Telicoplanin is a significant glycopeptide antibiotic used in the management of various bacterial infections.
1. General and Pharmacokinetic Information
| Aspect | Details |
| Source | Produced by Actinoplanes teichomyceticus |
| Chemical Class | Glycopeptide |
| Administration | Intravenous injection (for systemic infections), can also be used intramuscularly in some cases |
| Distribution | Distributes well in most body tissues, including bone, but has limited penetration into the cerebrospinal fluid without inflammation |
| Metabolism | Undergoes minimal metabolism in the body |
| Elimination | Primarily excreted unchanged in the urine, with a long elimination half – life of approximately 47 – 100 hours in adults |
2. Mechanism of Action
| Action | Explanation |
| Inhibition of Cell Wall Synthesis | Telicoplanin binds to the D – alanyl – D – alanine terminal of the lipid – linked peptidoglycan precursors in the cell wall of Gram – positive bacteria. This binding prevents the transglycosylation and transpeptidation reactions that are essential for the elongation and cross – linking of the peptidoglycan chains. As a result, the cell wall synthesis is disrupted, leading to cell lysis and death of the bacteria. |
3. Clinical Applications and Adverse Effects
| Category | Details |
| Clinical Applications | Used mainly for treating severe infections caused by Gram – positive bacteria. It is effective against methicillin – resistant Staphylococcus aureus (MRSA), Staphylococcus epidermidis, Streptococcus pyogenes, and Enterococcus faecalis. Indicated for skin and soft – tissue infections, bloodstream infections, endocarditis, and osteomyelitis. |
| Adverse Effects | Infusion – related reactions such as rash, pruritus, and rarely anaphylaxis can occur. Nephrotoxicity is a concern, especially with high doses or in patients with pre – existing renal impairment, manifested as increased serum creatinine levels. Thrombocytopenia may also be observed in some patients. |
Telicoplanin plays a crucial role in the treatment of Gram – positive bacterial infections, but its use needs to be carefully monitored to manage potential adverse effects.
If you're ready to take the next step, Leave your message below and we’ll reply soon. 20+ years of chemical manufacturing & export experience, a partner you can trust.



